Differentiation of NSCLC patients and healthy controls by a urinary microRNA panel

A. Wilke - Raamsteeboers (Enschede, Netherlands), C. Groothuis-Oudshoorn (Enschede, Netherlands), A. De Moor (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), J. De Rooij (Enschede, Netherlands), E. Citgez (Enschede, Netherlands)

Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Session: Novel methods, diagnostics and biomarkers of chronic lung diseases
Session type: Oral Presentation
Number: 3831

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Wilke - Raamsteeboers (Enschede, Netherlands), C. Groothuis-Oudshoorn (Enschede, Netherlands), A. De Moor (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), J. De Rooij (Enschede, Netherlands), E. Citgez (Enschede, Netherlands). Differentiation of NSCLC patients and healthy controls by a urinary microRNA panel. 3831

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers
Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Year: 2010

Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects.
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Quantitative RT-PCR 3-gene expression signature predicts survival in early-stage non-small cell lung cancer (NSCLC) patients (pts)
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009


Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

The comparison of subsets of blood lymphocytes in patients with lung cancer,COPD,and tuberculosis according to healthy controls
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001

Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival.
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Comparison of serum IL-18 levels in tuberculosis with pneumonia, lung cancer and healthy controls
Source: Eur Respir J 2003; 22: Suppl. 45, 340s
Year: 2003

Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005



Analysis and comparison of the transcriptome of COPD patients with and without lung cancer
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018



C-erbB-3 expression in non small cell lung cancer (NSCLC) patients treated by erlotinib
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Abnormal expression of let-7a miRNA in blood of lung cancer patient
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Gene expression profiling of induced sputum from COPD patients and healthy smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006